Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019The Tourette syndrome Therapeutics Market is forecast to Decline until 2019
By: Rajesh Gunnam $170.8m in 2011, and is forecast to decline at a Compound Annual Growth Rate (CAGR) of -3.3% to $130m by 2019. The current therapeutics market is served by approved drugs such as haloperidol and pimozide and off-label drugs such as Abilify (aripiprazole) The TS therapeutics market has two only approved drugs: haloperidol and pimozide. The other drugs used for the treatment of TS are used off-label, namely risperidone, clonidine and Abilify. Importantly, the approved drugs have inadequate levels of safety and efficacy, meaning that off-label drugs dominate treatment for TS. It has a low treatment seeking rate, as symptoms tend to disappear gradually with increasing age. Non-pharmacological treatment options such as behavioral therapy are also used, particularly for treating affected children and adolescen. The TS therapeutics pipeline has four molecules in development. Abilify is an off-label drug and is in the late stage of the pipeline. There are two products in Phase II and one in Phase I. This weak pipeline is not expected to intensify the competition in the market, currently centered on off-label products risperidone, clonidine and Abilify. This trend is likely to continue throughout the forecast period. For Sample Pages, please click or add the below link to your browser: http://www.globaldata.com/ GlobalData, the industry analysis specialist, has released its new report, “Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Tourette Syndrome Therapeutics market. The report identifies the key trends shaping and driving the global Tourette Syndrome Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Tourette Syndrome Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. For further details, please click or add the below link to your browser: http://www.globaldata.com/ Visit our report store: http://www.globaldata.com/ For more details contact: pressreleases@ North America: +1 646 395 5477 Europe: Asia Pacific: # # # GlobalData is a global market intelligence services company providing information research and analysis products and services. End
|